CoMFA and CoMSIA analyses on 4-oxo-1,4-dihydroquinoline and 4-oxo-1,4-dihydro-1,5-, -1,6- and -1,8-naphthyridine derivatives as selective CB2 receptor agonists
- 1 October 2009
- journal article
- Published by Springer Nature in Journal of Molecular Modeling
- Vol. 16 (4) , 677-691
Abstract
Novel classes of CB2 agonists based on 4-oxo-1,4-dihydroquinoline and 4-oxo-1,4-dihydro-1,5-, -1,6- and -1,8-naphthyridine scaffolds have shown high binding affinity toward CB2 receptor and good selectivity over CB1. A computational study of comparative molecular fields analysis (CoMFA) and comparative molecular similarity indices analysis (CoMSIA) was performed, in order to identify the key structural features impacting their binding affinity. The final CoMSIA model resulted to be the more predictive, showing $ r_{ncv}^2 = 0.84 $ , $ r_{cv}^2 = ~0.619 $ , SEE = 0.369, and $ r_{pred}^2 = 0.75 $ . The study provides useful suggestions for the synthesis of new selective analogues with improved affinity.
Keywords
This publication has 27 references indexed in Scilit:
- Investigations on the 4-Quinolone-3-carboxylic Acid Motif. 2. Synthesis and Structure−Activity Relationship of Potent and Selective Cannabinoid-2 Receptor Agonists Endowed with Analgesic Activity in VivoJournal of Medicinal Chemistry, 2008
- Cannabinoid CB2receptors: a therapeutic target for the treatment of inflammatory and neuropathic painBritish Journal of Pharmacology, 2008
- New 1,8-naphthyridine and quinoline derivatives as CB2 selective agonistsBioorganic & Medicinal Chemistry Letters, 2007
- Pharmacomodulations around the 4-Oxo-1,4-dihydroquinoline-3-carboxamides, a Class of Potent CB2-Selective Cannabinoid Receptor Ligands: Consequences in Receptor Affinity and FunctionalityJournal of Medicinal Chemistry, 2007
- The endocannabinoid system in targeting inflammatory neurodegenerative diseasesTrends in Pharmacological Sciences, 2007
- Cannabinoid CB2 receptor: a new target for controlling neural cell survival?Trends in Pharmacological Sciences, 2007
- Novel 4-Oxo-1,4-dihydroquinoline-3-carboxamide Derivatives as New CB2Cannabinoid Receptors Agonists: Synthesis, Pharmacological Properties and Molecular ModelingJournal of Medicinal Chemistry, 2005
- International Union of Pharmacology. XXVII. Classification of Cannabinoid ReceptorsPharmacological Reviews, 2002
- Seven-transmembrane receptors: crystals clarifyTrends in Pharmacological Sciences, 2002
- Molecular Similarity Indices in a Comparative Analysis (CoMSIA) of Drug Molecules to Correlate and Predict Their Biological ActivityJournal of Medicinal Chemistry, 1994